Page last updated: 2024-09-03

mozavaptan and Electrolytes

mozavaptan has been researched along with Electrolytes in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berkó, A; László, F; László, FA; Molnár, AH; Párducz, A; Rojik, I; Varga, C	1
Shimizu, K	1
Hropot, M; Kunick, C; Link, A	1
Chau, T; Inoue, T; Kawai, B; Koizumi, F; Kunihiro, N; Matsuo, A; Ohnishi, A; Okada, K; Tada, Y; Tanaka, T; Yamamura, Y	1
Ezure, Y; Fukaya, AY; Hasegaw, H; Koike, K; Kurasawa, T; Matsukawa, H; Naito, A; Naito, K; Oguma, T; Ohtake, Y; Shigenobu, K; Tanaka, H; Tsuriya, Y	1

Trials

2 trial(s) available for mozavaptan and Electrolytes

Article	Year
Combined effects of vasopressin V2 receptor antagonist and loop diuretic in humans. Clinical nephrology, 2003, Volume: 59, Issue:3 Topics: Adult; Benzazepines; Cross-Over Studies; Diuretics; Drug Therapy, Combination; Edema; Electrolytes; Furosemide; Hemodynamics; Humans; Hyponatremia; Male; Osmolar Concentration; Potassium; Regression Analysis; Renin; Sodium; Urination; Water	2003
Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis. Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:5 Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Dinoprostone; Diuresis; Electrolytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration	1998

Article

Year

Combined effects of vasopressin V2 receptor antagonist and loop diuretic in humans.

Clinical nephrology, 2003, Volume: 59, Issue:3

Topics: Adult; Benzazepines; Cross-Over Studies; Diuretics; Drug Therapy, Combination; Edema; Electrolytes; Furosemide; Hemodynamics; Humans; Hyponatremia; Male; Osmolar Concentration; Potassium; Regression Analysis; Renin; Sodium; Urination; Water

2003

Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.

Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:5

Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Dinoprostone; Diuresis; Electrolytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration

1998

Other Studies

3 other study(ies) available for mozavaptan and Electrolytes

Article	Year
Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260. Progress in brain research, 2008, Volume: 170 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Water; Brain; Brain Edema; Carotid Arteries; Disease Models, Animal; Electrolytes; Humans; Hypoxia, Brain; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Survival Rate	2008
Synthesis and in vivo testing of a potential aquaretic agent. Die Pharmazie, 1996, Volume: 51, Issue:8 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Electrolytes; Male; Rats; Rats, Wistar; Water-Electrolyte Balance	1996
Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in rats. Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Diuretics; Electrolytes; Female; Furosemide; Male; Mice; Mice, Inbred ICR; Pyrroles; Quinoxalines; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Receptors, Vasopressin; Urodynamics	2000